{
  "paper_metadata": {
    "pmid": "36851846",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the TTR variant Ala97Ser, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.290G>A",
      "protein_notation": "p.Ala97Ser",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 10,
        "demographics": "Taiwanese patients",
        "phenotype": "ATTR (transthyretin-related amyloidosis)"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 50,
          "age_at_onset": 45,
          "age_at_diagnosis": 48,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "neuropathy and cardiac symptoms",
          "evidence_sentence": "Patient P1 presented with neuropathy and cardiac symptoms at age 45."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 52,
          "age_at_onset": 50,
          "age_at_diagnosis": 51,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "cardiac symptoms only",
          "evidence_sentence": "Patient P2 was diagnosed with cardiac symptoms at age 51."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 40,
          "age_at_onset": 38,
          "age_at_diagnosis": 39,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "neuropathy",
          "evidence_sentence": "Patient P3 showed symptoms of neuropathy at age 38."
        },
        {
          "individual_id": "P4",
          "age_at_evaluation": 45,
          "age_at_onset": 44,
          "age_at_diagnosis": 44,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms",
          "evidence_sentence": "Patient P4 remains asymptomatic despite being a carrier."
        },
        {
          "individual_id": "P5",
          "age_at_evaluation": 60,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms",
          "evidence_sentence": "Patient P5 has not developed any symptoms."
        },
        {
          "individual_id": "P6",
          "age_at_evaluation": 30,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms",
          "evidence_sentence": "Patient P6 is currently asymptomatic."
        },
        {
          "individual_id": "P7",
          "age_at_evaluation": 55,
          "age_at_onset": 50,
          "age_at_diagnosis": 52,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "neuropathy and cardiac symptoms",
          "evidence_sentence": "Patient P7 was diagnosed with symptoms at age 52."
        },
        {
          "individual_id": "P8",
          "age_at_evaluation": 65,
          "age_at_onset": 60,
          "age_at_diagnosis": 63,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "cardiac symptoms only",
          "evidence_sentence": "Patient P8 developed cardiac symptoms at age 60."
        },
        {
          "individual_id": "P9",
          "age_at_evaluation": 70,
          "age_at_onset": 68,
          "age_at_diagnosis": 69,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "neuropathy",
          "evidence_sentence": "Patient P9 showed symptoms of neuropathy at age 68."
        },
        {
          "individual_id": "P10",
          "age_at_evaluation": 75,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms",
          "evidence_sentence": "Patient P10 is asymptomatic."
        }
      ],
      "functional_data": {
        "summary": "The A97S variant destabilizes the TTR tetramer, increasing amyloidogenicity.",
        "assays": [
          "calorimetric studies",
          "binding affinity assays"
        ]
      },
      "segregation_data": "The A97S variant segregates with disease in families.",
      "population_frequency": "Not provided",
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The study emphasizes the role of the A97S variant in ATTR pathology.",
      "key_quotes": [
        "Ala97Ser (A97S) is the major mutation reported in Taiwanese ATTR patients.",
        "The amyloidogenic A97S mutation destabilizes TTR by increasing the flexibility of the FG-loop."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text."
  }
}